Ticker

Poolbeg Pharma PLC (AIM:POLB, OTC:POLBF, FRA:POLBF), the AIM-listed clinical-stage biopharmaceutical company, has received clinical trial authorisation from the UK Medicines and Healthcare products Regulatory Agency for its TOPICAL trial, with interim data expected this summer. The trial is investigating POLB 001, which is being developed as a potential first-approved preventative therapy for cytokine release…

OCALA, Fla., April 13, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today advised that its audited consolidated financial statements for the fiscal year ended December 31, 2025, contained an audit report from its independent registered public accounting firm with a going concern emphasis of matter. Release of this information is required by Section 610(b) of the NYSE…

Seeing Machines Ltd (AIM:SEE, OTC:SEEMF, FRA:M2Z) told investors it has so far found no evidence of unauthorised access to its systems or data, after investigating an alleged cyber threat flagged to the company around 10 days ago. The AIM-listed transport safety technology group said a third party had named it online alongside claims that some company data had been accessed.

Impax Asset Management (AIM:IPX, FRA:LW4) shares dropped in Friday morning's deals, losing 21% to 98.68p, as the firm reported assets under management fell 8% over its fiscal second quarter to £22.3 billion, as continued client redemptions prompted the AIM-listed specialist investor to guide for lower full-year revenue. Net outflows totalled £2.01 billion in the three months to 31 March 2026, driven principally by…

Union Jack Oil PLC (AIM:UJO, OTCQB:UJOGF, FRA:1UJ0) has announced that the Crossroads well in southern Oklahoma is set to be spudded on or around 16 April, giving investors a near-term drilling catalyst on a project where the company already has its funding in place. The AIM-listed group holds a 43% interest in Crossroads, with Reach Oil and Gas acting as operator, and, Union Jack said its share of drilling costs…